Association between serum 25-hydroxyvitamin D and arterial stiffness in non-dialysis-dependent CKD. (Q41388500)

30 September 2017

Association between serum 25-hydroxyvitamin D and arterial stiffness in non-dialysis-dependent CKD. (English)

1 reference

30 September 2017

0 references

Q Luo

1

1 reference

30 September 2017

L L Wang

series ordinal

2

1 reference

30 September 2017

Y H Gao

series ordinal

3

1 reference

30 September 2017

9 September 2015

1 reference

European Journal of Clinical Nutrition

30 September 2017

1 reference

30 September 2017

70

1 reference

30 September 2017

274-276

1 reference

30 September 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1038/ejcn.2015.146

30 September 2017

0 references

cites work

25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2015.146

Circulating 25-Hydroxy-Vitamin D and Risk of Cardiovascular Disease: A Meta-Analysis of Prospective Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2015.146

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2015.146

Plasma 25-hydroxyvitamin D levels and risk of incident hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2015.146

25-Hydroxyvitamin D Levels and Risk of Ischemic Heart Disease, Myocardial Infarction, and Early Death: Population-Based Study and Meta-Analyses of 18 and 17 Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2015.146

Reduced vitamin D in acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2015.146

Active serum vitamin D levels are inversely correlated with coronary calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2015.146

Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2015.146

Role of integrins in endothelial mechanosensing of shear stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2015.146

Brachial-ankle pulse wave velocity predicts decline in renal function and cardiovascular events in early stages of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2015.146

Vitamin D status and its association with mineral and bone disorder in a multi-ethnic chronic kidney disease population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2015.146

An association between decreased estimated glomerular filtration rate and arterial stiffness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2015.146

Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2015.146

Advanced glycation end products and diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2015.146

Long-term trandolapril treatment is associated with reduced aortic stiffness: the prevention of events with angiotensin-converting enzyme inhibition hemodynamic substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2015.146

Angiotensin receptor blockade and arterial compliance in chronic kidney disease: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2015.146

Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2015.146

FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2015.146

Large Artery Stiffening and Remodeling Are Independently Associated With All-Cause Mortality and Cardiovascular Events in Chronic Kidney Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2015.146

1,25-Dihydroxyvitamin D3 regulation of cardiac myocyte proliferation and hypertrophy

21 January 2018

1 reference

12 December 2020

Increased levels of serum parathyroid hormone and fibroblast growth factor-23 are the main factors associated with the progression of vascular calcification in long-hour hemodialysis patients

1 reference

12 December 2020

1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system

1 reference

12 December 2020

Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement

1 reference

12 December 2020

Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease

1 reference

12 December 2020

Pulse wave velocity and vascular calcification at different stages of chronic kidney disease

1 reference

12 December 2020

Chapter 1: Definition and classification of CKD

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2015.146

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/EJCN.2015.146

1 reference

Dimensions Publication ID

30 September 2017

0 references

1 reference